PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. (Q38384991)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. |
scientific article |
Statements
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI (English)
Dean J Kereiakes
Alejandro Vasquez
Marc Klapholz
Gary L Schaer
Stephen Frohwein
Timothy D Henry
Richard A Schatz
Nabil Dib
Catalin Toma
Charles J Davidson
Gregory W Barsness
David M Shavelle
Martin Cohen
Joseph Poole
Thomas Moss
Pamela Hyde
Anna Maria Kanakaraj
Vitaly Druker
Amy Chung
Candice Junge
Robert A Preti
Robin L Smith
David J Mazzo
Andrew Pecora
Douglas W Losordo
7 November 2016
1 reference
1 reference
1 reference
1 reference